Medesis Pharma SA (ALMDP) — Net Asset Quality Index
Medesis Pharma SA (ALMDP) has a Net Asset Quality Index of -242.0% as of June 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €2.11 Million minus total liabilities of €7.20 Million yields net assets of €-5.10 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of Medesis Pharma SA to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Medesis Pharma SA Net Asset Quality Index Over Time (2018–2023)
This chart shows how Medesis Pharma SA's Net Asset Quality Index has evolved across 6 annual periods from 2018 to 2023. As of June 2024, the index stands at -242.0%, representing net assets of €-5.10 Million against total assets of €2.11 Million EUR. See working capital position of Medesis Pharma SA to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Medesis Pharma SA (2018–2023)
The table below presents the year-by-year Net Asset Quality Index for Medesis Pharma SA from 2018 to 2023, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Medesis Pharma SA market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2023 | -233.6% | €-4.50 Million | €1.93 Million | €6.43 Million | ▼ -178.4 pp |
| 2022 | -55.2% | €-1.06 Million | €1.92 Million | €2.97 Million | ▼ -93.3 pp |
| 2021 | 38.0% | €1.65 Million | €4.33 Million | €2.68 Million | ▲ +286.6 pp |
| 2020 | -248.6% | €-2.08 Million | €837.91K | €2.92 Million | ▲ +90.1 pp |
| 2019 | -338.7% | €-2.42 Million | €714.00K | €3.13 Million | ▼ -284.7 pp |
| 2018 | -53.9% | €-876.00K | €1.62 Million | €2.50 Million | — |